Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior

This publication has 12 references indexed in Scilit:

• Clinical and Biochemical Evidence of Control of Prostate Cancer at 5 Years After External Beam Radiation
  Journal of Urology, 1995
• Observations of pretreatment prostate-specific antigen doubling time in 107 patients referred for definitive radiotherapy
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
• Relationship of tumor DNA-ploidy toserum prostate-specific antigen doubling time after radiotherapy for prostate cancer
  Urology, 1994
• Proliferative cell nuclear antigen in postradiotherapy prostate biopsies
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
• Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases
  Urology, 1994
• Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer
  Cancer, 1993
• Prostatic-specific antigen doubling times in patients with prostate cancer: A potentially useful reflection of tumor doubling time
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993
• Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume
  Cancer, 1993
• Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated Patients
  Journal of Urology, 1989
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958